PriceTargets.com logo

OTCMKTS:JDHIF - JD Health International Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$19.00 As of 02/24/2021 04:10 PM ET
▼ -1.25 (-6.17%)
1 month | 3 months | 12 months
Get New JD Health International Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for JDHIF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for JDHIF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for JD Health International in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $19.00.
Buy
The current consensus among 1 investment analysts is to buy stock in JD Health International.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/3/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/2/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
1/14/2021Jefferies Financial GroupInitiated CoverageBuy
i
(Data available from 2/24/2016 forward)
JD Health International logo
JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products through direct selling and online retail pharmacy network. The company also provides online healthcare services, such as online consultation and prescription renewal, chronic disease management, family doctor, and consumer healthcare services, as well as health management and intelligent healthcare solutions. In addition, its platform allows users to make appointments and pay for services, such as general physical exams, aesthetic medicines, vaccination appointments, dental care services, and genetic tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Read More

Today's Range

Now: $19.00
$19.00
$19.00

50 Day Range

MA: N/A

52 Week Range

Now: $19.00
$17.75
$22.60

Volume

3,818 shs

Average Volume

832 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of JD Health International?

The following Wall Street analysts have issued research reports on JD Health International in the last twelve months: Jefferies Financial Group Inc..
View the latest analyst ratings for JDHIF.

What is the current price target for JD Health International?

0 Wall Street analysts have set twelve-month price targets for JD Health International in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for JD Health International in the next year.
View the latest price targets for JDHIF.

What is the current consensus analyst rating for JD Health International?

JD Health International currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe JDHIF will outperform the market and that investors should add to their positions of JD Health International.
View the latest ratings for JDHIF.

What other companies compete with JD Health International?

Other companies that are similar to JD Health International include Asian American Medical Group, CareRx, Encompass Health, FarmaForce Limited (FFC.AX), Field Trip Health, Fresenius SE & Co. KGaA, Greenbrook TMS, Healthia, Life Healthcare Group, Medicover AB (publ), Orpea, Ramsay Health Care, Sienna Senior Living and Tenet Healthcare.